美国 · SEC FORM 4
SHOULDER INNOVATIONS, INC.
SI · NYSE · CIK 0001699350 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
29 同一窗口内观察到的 Form 4 交易行
17 sales · 12 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-03-13 · Points Jeffrey S..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -7.9%
- 3M
- -11.1%
- 6M
- +30.2%
- 12M
- —
波动率与流动性
- 波动率
- 68.5%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- -85.3%
- ROE
- -28.7%
- 细分行业
- Medical Devices
市场数据
价格数据截至：2026-10-04 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 630,244
- 上期报告
- 419,759
- 日均成交量
- 163,233
- 回补天数
- 3.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-13 | Points Jeffrey S. | 买入 (P) | Common Stock | 2,000 | USD 15.00 | USD 30,000 | SEC 申报 ↗ |
| 2026-03-13 | Buchholz Richard | 买入 (P) | Common Stock | 1,000 | USD 14.84 | USD 14,840 | SEC 申报 ↗ |
| 2026-03-13 | Ball Robert Joseph | 买入 (P) | Common Stock | 2,200 | USD 15.18 | USD 33,396 | SEC 申报 ↗ |
| 2025-12-12 | Points Jeffrey S. | 买入 (P) | Common Stock | 1,005 | USD 14.98 | USD 15,055 | SEC 申报 ↗ |
| 2025-12-12 | Ball Robert Joseph | 买入 (P) | Common Stock | 3,900 | USD 14.89 | USD 58,071 | SEC 申报 ↗ |
| 2025-12-11 | Points Jeffrey S. | 买入 (P) | Common Stock | 995 | USD 14.65 | USD 14,577 | SEC 申报 ↗ |
| 2025-12-11 | Ball Robert Joseph | 买入 (P) | Common Stock | 3,300 | USD 14.83 | USD 48,939 | SEC 申报 ↗ |
| 2025-09-12 | Points Jeffrey S. | 买入 (P) | Common Stock | 1,600 | USD 15.67 | USD 25,072 | SEC 申报 ↗ |
| 2025-09-12 | Ball Robert Joseph | 买入 (P) | Common Stock | 6,000 | USD 15.49 | USD 92,940 | SEC 申报 ↗ |
| 2025-09-11 | Ball Robert Joseph | 买入 (P) | Common Stock | 2,000 | USD 14.90 | USD 29,800 | SEC 申报 ↗ |
| 2025-08-01 | Tansey Casey M | 买入 (P) | Common Stock | 40,000 | USD 15.00 | USD 600,000 | SEC 申报 ↗ |
| 2025-08-01 | Points Jeffrey S. | 买入 (P) | Common Stock | 50 | USD 15.00 | USD 750 | SEC 申报 ↗ |
| 2025-08-01 | Pardo Geoffrey B | 买入 (P) | Common Stock | 100,000 | USD 15.00 | USD 1,500,000 | SEC 申报 ↗ |
| 2025-08-01 | Gilde Healthcare Holding B.V. | 买入 (P) | Common Stock | 100,000 | USD 15.00 | USD 1,500,000 | SEC 申报 ↗ |
| 2025-08-01 | George Jean; LSV Associates II, LLC; Lightstone Ventures II (A), L.P.; Lightstone Ventures II, L.P.; Plain Henry A JR | 买入 (P) | Common Stock | 266,666 | USD 15.00 | USD 3,999,990 | SEC 申报 ↗ |
Form 4 申报证据
49 transaction lines in the latest 365-day window; 84 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Tansey Casey M | 奖励／授予 (A) | Common Stock | 733 | USD 19.60 | USD 14,367 | SEC 申报 ↗ |
| 2026-10-05 | Sidow Kevin K. | 奖励／授予 (A) | Common Stock | 892 | USD 19.60 | USD 17,483 | SEC 申报 ↗ |
| 2026-10-05 | Hykes Andrew | 奖励／授予 (A) | Common Stock | 669 | USD 19.60 | USD 13,112 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Tansey Casey M | 奖励／授予 (A) | Common Stock | 733 | USD 19.60 | USD 14,367 | SEC 申报 ↗ |
| 2026-10-05 | Sidow Kevin K. | 奖励／授予 (A) | Common Stock | 892 | USD 19.60 | USD 17,483 | SEC 申报 ↗ |
| 2026-10-05 | Hykes Andrew | 奖励／授予 (A) | Common Stock | 669 | USD 19.60 | USD 13,112 | SEC 申报 ↗ |
| 2026-10-05 | BUCKMAN PAUL | 奖励／授予 (A) | Common Stock | 1,275 | USD 19.60 | USD 24,990 | SEC 申报 ↗ |
| 2026-09-14 | Ball Robert Joseph | 卖出 (S) | Common Stock | 10,175 | USD 18.45 | USD 187,729 | SEC 申报 ↗ |
| 2026-09-14 | Ball Robert Joseph | 期权行权／转换 (M) | Common Stock | 89,233 | USD 2.10 | USD 187,389 | SEC 申报 ↗ |
| 2026-08-26 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 1,196 | USD 22.60 | USD 27,030 | SEC 申报 ↗ |
| 2026-08-24 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 681 | USD 22.62 | USD 15,404 | SEC 申报 ↗ |
| 2026-08-21 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 20,516 | USD 22.61 | USD 463,867 | SEC 申报 ↗ |
| 2026-08-20 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 3,900 | USD 22.60 | USD 88,140 | SEC 申报 ↗ |
| 2026-08-18 | Ahearn Matthew Fraser | 卖出 (S) | Common Stock | 14,186 | USD 20.99 | USD 297,759 | SEC 申报 ↗ |
| 2026-08-17 | Ahearn Matthew Fraser | 卖出 (S) | Common Stock | 8,314 | USD 20.10 | USD 167,111 | SEC 申报 ↗ |
| 2026-08-14 | Ahearn Matthew Fraser | 赠与 (G) | Common Stock | 2,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-06 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 2,095 | USD 22.60 | USD 47,347 | SEC 申报 ↗ |
| 2026-08-05 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 7,338 | USD 22.64 | USD 166,132 | SEC 申报 ↗ |
| 2026-08-04 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 99,812 | USD 22.77 | USD 2,272,719 | SEC 申报 ↗ |
| 2026-08-03 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 10,751 | USD 22.71 | USD 244,155 | SEC 申报 ↗ |
| 2026-07-31 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 20,034 | USD 22.73 | USD 455,373 | SEC 申报 ↗ |
| 2026-07-30 | Gilde Healthcare Holding B.V. | 卖出 (S) | Common Stock | 28,245 | USD 23.36 | USD 659,803 | SEC 申报 ↗ |
| 2026-06-26 | Tansey Casey M | 奖励／授予 (A) | Common Stock | 5,046 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-26 | Sidow Kevin K. | 奖励／授予 (A) | Common Stock | 5,046 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-26 | Hykes Andrew | 奖励／授予 (A) | Common Stock | 5,046 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-26 | Buchholz Richard | 奖励／授予 (A) | Common Stock | 5,046 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-26 | BUCKMAN PAUL | 奖励／授予 (A) | Common Stock | 5,046 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Ahearn Matthew Fraser | 卖出 (S) | Common Stock | 4,144 | USD 18.84 | USD 78,071 | SEC 申报 ↗ |
| 2026-06-12 | Ahearn Matthew Fraser | 卖出 (S) | Common Stock | 15,856 | USD 18.68 | USD 296,190 | SEC 申报 ↗ |
| 2026-04-30 | Ball Robert Joseph | 期权行权／转换 (M) | Common Stock | 10,000 | USD 2.48 | USD 24,800 | SEC 申报 ↗ |
| 2026-04-20 | Ahearn Matthew Fraser | 期权行权／转换 (M) | Common Stock | 21,664 | USD 2.73 | USD 59,139 | SEC 申报 ↗ |
| 2026-03-13 | Points Jeffrey S. | 买入 (P) | Common Stock | 2,000 | USD 15.00 | USD 30,000 | SEC 申报 ↗ |
| 2026-03-13 | Points Jeffrey S. | 期权行权／转换 (M) | Common Stock | 13,264 | USD 2.48 | USD 32,895 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SI |
| CIK | 0001699350 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 84 transaction lines from 2025-08-01 to 2026-10-05 17 P purchase lines · 17 S sale lines · 50 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.